NCT00454662View on ClinicalTrials.gov

Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)

PHASE4CompletedINTERVENTIONAL

Enrollment

5,141

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions

HypertensionCardiovascular DiseaseDiabetes

Interventions

DRUG

olmesartan medoxomil / amlodipine or azelnidipine

AT1 subtype angiotensin II receptor antagonist / calcium channel blocker : 5-40mg of olmesartan medoxomil / 2.5-5mg of amlodipine or 8-16mg of azelnidipine

DRUG

olmesartan medoxomil / low dose thiazide type drug

AT1 subtype angiotensin II receptor antagonist / low dose diuretic : 5-40mg of olmesartan medoxomil / low dose thiazide type drug

Trial Locations (1)

105-0001

COLM-Study Data Center, Kamiyacho Mount Bld.14F, 4-3-20 Toranomon Minato-ku

All Listed Sponsors

collaborator

Japan Heart Foundation

OTHER

lead

COLM Study Research Organization

OTHER

NCT00454662 - Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study) | Biotech Hunter | Biotech Hunter